Olivier Favre-Bulle

Olivier Favre-Bulle is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Founder, CEO, and Consultant in Drug Development at 3Biotech since January 2014, focusing on accelerating therapeutic innovations. In addition, Olivier holds positions as Expert for France 2030 at Le Cercle des experts Bpifrance, Chief Technology Officer at ABCELY, Head of CMC at Domain Therapeutics, CMC Consultant roles at CEVA SANTE ANIMALE and Amolyt Pharma, and CMC Director at Apaxen. Previous experience includes CMC advising at Advesya and leading CMC operations at AbolerIS Pharma. Olivier's educational background includes a Ph.D. in Biotechnology from the University of Groningen, an MBA in Finance and Accounting from SIMI, and an engineering degree in Chemistry from Ecole Nationale Supérieure de Chimie de Montpellier.